Dusseldorf - Delayed Quote • EUR
Cidara Therapeutics Inc (20D.DU)
At close: April 23 at 7:30 PM GMT+2
Growth Estimates
CURRENCY IN USD | 20D.DU | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | -- |
Next Qtr. | -- | -- | -- | -- |
Current Year | -- | -- | -- | -- |
Next Year | -- | -- | -- | -- |
Next 5 Years (per annum) | -- | -- | -- | -- |
Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
Reiterates | Cantor Fitzgerald: Overweight | 4/23/2024 |
Maintains | HC Wainwright & Co.: Buy to Buy | 4/8/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 12/7/2023 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 11/6/2023 |
Reiterates | Needham: Buy to Buy | 9/22/2023 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 9/22/2023 |
Related Tickers
ALGS Aligos Therapeutics, Inc.
0.7820
-4.40%
INZY Inozyme Pharma, Inc.
4.4400
+2.54%
HOOK HOOKIPA Pharma Inc.
0.8933
+10.82%
VNDA Vanda Pharmaceuticals Inc.
4.6200
+3.12%
EFTR eFFECTOR Therapeutics, Inc.
1.8900
+4.42%
PDSB PDS Biotechnology Corporation
3.2700
+0.31%
ARDX Ardelyx, Inc.
6.42
+1.74%
HRTX Heron Therapeutics, Inc.
2.4500
-3.92%
VKTX Viking Therapeutics, Inc.
74.31
+7.91%